Which company develops and produces Seleniso?

Selinexor is developed and produced by Karyopharm Therapeutics, an American pharmaceutical company. Karyopharm Therapeutics was established in 2008 and focuses on developing innovative cancer treatment drugs, especially drugs targeting the nuclear protein transport pathway.

The company's research focuses on nuclear protein transport, a cell biological process that plays an important role in maintaining normal cell function and regulating gene expression. Karyopharm TherapeuticsScientists discovered seleniso, a nuclear proteinXPO1 inhibitor, through in-depth research on the regulatory mechanism of nuclear protein transport, and used it as a potential new drug to treat cancer.

The research and development of selinesol has gone through multiple clinical trial stages, and has shown significant efficacy in the treatment of hematological tumors such as multiple myeloma. This result enabled selinesol to be approved by the U.S. Food and Drug Administration (FDA) in 2019 as a new type of anti-cancer drug.

Karyopharm Therapeutics is committed to providing patients with more treatment options through scientific innovation and drug development. In addition to selinesol, the company is also developing other drugs in different fields, aiming to meet the medical needs of major diseases such as cancer.

Seleniso is already on the market in China and has been included in medical insurance, but its price is quite expensive, about 10,000 to 20,000 yuan, making patients bear higher treatment costs. It is recommended to consult the local hospital pharmacy for specific prices and medical insurance reimbursement status. Different from the domestic market, Seleniso has two options: original drug and generic drug in the foreign market. The original drug is the American version of the original drug. Because of its higher research and development costs, the price is even more expensive, even as high as hundreds of thousands of yuan. In comparison, generic drugs are more affordable. Lao generic drugs are one of the relatively low-priced generic drugs, with prices ranging from 2,000 yuan to 4,000 yuan. Compared with original drugs, they are more affordable. The ingredients of original drugs and generic drugs are basically the same.